Miami, Florida
Miami, Florida
QPS Folrida
6141 Sunset Drive, Suite 301, South Miami, Florida 33143, USA
Phase I Beds
Board Certified PIs
Square-Foot of Lab Space


The QPS location in Miami, Florida is a multi-specialty research center with 150+ employees, including board-certified physicians, in a 32,000 square foot space.

Core Competencies
  • Phase I → IV clinical studies.
  • Phase I study types include: SAD/MAD, BE/BA, PK/PD, food effects, QTC, proof of concept, drug interactions and biologics.
  • Study patient populations include: elderly, pediatrics, and post-menopausal women.
  • Study Indications include: NASH, fatty liver, diabetes, OA/RA, ADHD, depression, sleep, vaccine, Parkinson’s disease, Alzheimer’s disease, migraines, gout, male hypogonadism, obesity, cholesterol, hypertension, renal/hepatic impairment, women’s health, and more.
  • Vaccine research study experience includes: Zika, Ebola, Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Respiratory Syncytial Virus (RSV), Pneumococcus, Influenza, and more.
  • Full-service clinical laboratory.
  • Peripheral blood mononuclear cell (PBMC) laboratory.
  • USP 797-compliant pharmacy with compounding capability.
  • 90-bed Phase I unit.
  • Late Phase clinical trial facility.
  • Access to Wireless Telemetry, Ultrasound, Dual Energy X-Ray Absorptiometry (DEXA), Polysomnography (PSG), Magnetic Resonance Angiography (MRA), Computed Tomography (CT), X-Ray, and Holter monitoring.
  • Refrigerated centrifuges.
  • Electronic lab transfers.
  • RSVP system – a fingerprinting system to prevent patients from entering multiple studies at the same time.
  • Sleep lab.
  • In-house specialized patient recruitment and advertising agency.
  • Call-center staffed with experienced research counselors.
  • 5 principal investigators (PIs), board-certified in various fields, including rheumatology, internal medicine, psychiatry, neurology, sleep, dermatology, and gastroenterology, with additional access to a wide variety of specialty physicians.
  • 5 nurse practitioners.
  • 2 pharmacists.
  • 15 nurses.
  • 30 support staff including: study coordinators (with, on average, 6 years of research experience), QA/QC personnel, nurses, and regulatory personnel.
  • 12 routine FDA audits over the past 9 years and no 483s issued.
  • A robust database of 30,000 subjects/patients.
  • Association for the Accreditation of Human Research Protection Program (AAHRPP) accredited.
  • Lab is Clinical Laboratory Improvement Amendments (CLIA) and Commission on Office Laboratory Accreditation (COLA) accredited.
  • All staff are trained in good clinical practices (GCP).
  • Coordinators are trained on basic life support (BLS).
  • Over 1,200 clinical studies conducted across Phase I, Late Phase and Vaccines.